| scholarly article | Q13442814 |
| P50 | author | Barbara A Parker | Q89601570 |
| P2093 | author name string | Gail A Laughlin | |
| Cheryl L Rock | |||
| Loki Natarajan | |||
| John P Pierce | |||
| Ruth E Patterson | |||
| Dennis D Heath | |||
| Shirley W Flatt | |||
| Nazmus Saquib | |||
| Kirsten Erickson | |||
| P2860 | cites work | International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | Q24642456 |
| Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial | Q24675035 | ||
| The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
| Does diabetes care compete with the provision of women's preventive care services? | Q28192911 | ||
| Medical comorbidities predict mortality in women with a history of early stage breast cancer | Q33956785 | ||
| Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older | Q34141839 | ||
| Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis | Q34976375 | ||
| Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis | Q35515271 | ||
| Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors | Q35814623 | ||
| Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006 | Q37067113 | ||
| Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer | Q37171293 | ||
| Insulin receptors in breast cancer. | Q40999350 | ||
| Insulin receptors in breast cancer: biological and clinical role | Q41105014 | ||
| Diabetes, prediabetes and cancer mortality | Q43057683 | ||
| Waist-to-hip ratio and breast cancer mortality | Q43539419 | ||
| Fasting serum glucose level and cancer risk in Korean men and women | Q43943327 | ||
| Insulin receptor expression and clinical outcome in node-negative breast cancer | Q44857623 | ||
| Comorbidity as a predictor of stage of illness for patients with breast cancer | Q45269985 | ||
| A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. | Q46007340 | ||
| Utility of A1C for diabetes screening in the 1999 2004 NHANES population | Q46190799 | ||
| Comorbidity and breast cancer survival: a comparison between black and white women | Q46238624 | ||
| Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study | Q46407679 | ||
| The effect of comorbidity on 3-year survival of women with primary breast cancer | Q46637774 | ||
| Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer | Q46912411 | ||
| Metabolic syndrome as a prognostic factor for breast cancer recurrences | Q46922126 | ||
| Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis | Q47342821 | ||
| Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. | Q51545574 | ||
| Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer | Q57895974 | ||
| The impact of diabetes on survival following breast cancer | Q60595423 | ||
| Diabetes and Cancer: A Consensus Report | Q62267706 | ||
| Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer | Q67789544 | ||
| Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival | Q69941671 | ||
| The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer | Q70799897 | ||
| Screening mammogram utilization in women with diabetes | Q77292252 | ||
| Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study | Q81514278 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 54-60 | |
| P577 | publication date | 2010-11-29 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer | |
| P478 | volume | 29 |
| Q37723241 | Acute Hyperglycemia Associated with Anti-Cancer Medication. |
| Q37672164 | An Elevated HbA1c Level Is Associated With Short-Term Adverse Outcomes in Patients With Gastrointestinal Cancer and Type 2 Diabetes Mellitus |
| Q36521413 | Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening. |
| Q35094977 | Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women |
| Q36059119 | Associations between Diabetes and Quality of Life among Breast Cancer Survivors |
| Q92823863 | Associations between Dietary Acid Load and Biomarkers of Inflammation and Hyperglycemia in Breast Cancer Survivors |
| Q34558255 | Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. |
| Q47311801 | Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis |
| Q37002946 | Cancer Prevention: Obstacles, Challenges and the Road Ahead. |
| Q34168190 | Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance) |
| Q44459340 | Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. |
| Q36246468 | Diabetes and Breast Cancer Subtypes. |
| Q47665989 | Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System |
| Q36229115 | Diabetes and breast cancer mortality in Black women. |
| Q26822753 | Diabetes and cancer: two diseases with obesity as a common risk factor |
| Q30240165 | Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis |
| Q35373602 | Diabetes, diabetes treatment and breast cancer prognosis |
| Q37303867 | Diabetes, metformin, and breast cancer in postmenopausal women |
| Q34414818 | Diabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients |
| Q38040690 | Diet and breast cancer: understanding risks and benefits |
| Q28069088 | Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer |
| Q35014899 | Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort |
| Q33555255 | Does cancer risk increase with HbA1c, independent of diabetes? |
| Q36047132 | Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study |
| Q34520129 | Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. |
| Q40781176 | Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study |
| Q41338278 | Ethnicity differences in breast cancer stage at the time of diagnosis in Norway |
| Q48229894 | Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor? |
| Q36594091 | Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type |
| Q94547358 | Fasting to enhance Cancer treatment in models: the next steps |
| Q61450753 | Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors |
| Q57215030 | Glycated Hemoglobin and Cancer Risk in Korean Adults: Results from Korean Genome and Epidemiology Study |
| Q90445914 | Glycosylated Hemoglobin A1c Is Associated with Anthropometric Measurements and Tumor Characteristics in Breast Cancer Patients |
| Q88154096 | Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus |
| Q40347780 | HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus. |
| Q89895146 | Hemoglobin A1c Levels Modify Associations between Dietary Acid Load and Breast Cancer Recurrence |
| Q36194195 | Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer |
| Q36165176 | Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients |
| Q34609703 | Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China |
| Q42138621 | Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life |
| Q35997957 | Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist. |
| Q35878469 | Lifestyle interventions for cardiovascular risk reduction in women with breast cancer |
| Q37154242 | Mechanisms linking obesity and cancer |
| Q51107564 | Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index. |
| Q35684565 | Metabolic syndrome and triple-negative breast cancer: a new paradigm |
| Q33973037 | Metabolic syndrome in breast cancer |
| Q50993656 | Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial. |
| Q99557781 | MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus |
| Q28253823 | Molecular mechanisms of cancer development in obesity |
| Q36519778 | Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia |
| Q39024774 | Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation |
| Q35137438 | On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test. |
| Q36279708 | Physical activity levels of overweight or obese breast cancer survivors: correlates at entry into a weight loss intervention study |
| Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
| Q36027036 | Pre-existing diabetes and breast cancer prognosis among elderly women. |
| Q41248320 | Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease |
| Q37013537 | Prevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c: A cross-sectional study in Croatia |
| Q36633217 | Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy |
| Q38381319 | Prolonged Nightly Fasting and Breast Cancer Prognosis |
| Q47567147 | Protein kinase C δ-dependent regulation of Ubiquitin-proteasome system function in breast cancer |
| Q36757714 | Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors |
| Q37483954 | Relationship between level of HbA1C and breast cancer |
| Q34340949 | Restricting carbohydrates to fight head and neck cancer-is this realistic? |
| Q28066027 | Role of n-3 Polyunsaturated Fatty Acids and Exercise in Breast Cancer Prevention: Identifying Common Targets |
| Q40707324 | Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? |
| Q35153493 | Survival of patients with stage IV lung cancer with diabetes treated with metformin |
| Q36863215 | Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer |
| Q91922006 | The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy |
| Q37579337 | The association between adiposity and breast cancer recurrence and survival: A review of the recent literature |
| Q87898837 | The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors |
| Q35913204 | The impact of diabetes mellitus on prognosis of early breast cancer in Asia |
| Q84617977 | The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden |
| Q26852910 | The links between insulin resistance, diabetes, and cancer |
| Q38180008 | Treatment and outcomes in diabetic breast cancer patients |
| Q38835481 | Type 2 diabetes, insulin treatment and prognosis of breast cancer |
| Q30572730 | Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? |
| Q47795004 | Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions |
Search more.